RxP Update

Discussion in 'Psychology [Psy.D. / Ph.D.]' started by edieb, Nov 14, 2005.

  1. edieb

    edieb Senior Member
    10+ Year Member

    Aug 27, 2004
    Likes Received:
    It looks like Louisiana is planning on pushing a bill that will let medical psychologists begin prescribing in state hospitals and other inpatient facilities:

    In our last column we were able to share with the readership
    the prescribing experiences of Louisiana Psychological Association
    (LPA) President Jim Quillin, which have uniformly been positive. To
    date, LPA Medical Psychologists have prescribed “better than 4,000
    scripts.” “At this point, prescribing, therapeutic monitoring, etc.,
    as part of my practice, has become fairly routine, as it did with the
    DoD grads. The ‘death in the streets’ argument that our opponents
    always use against us, as you know, is just blue smoke and
    mirrors.... Moreover, the fear that we will stop being psychologists
    if we prescribe, as it turns out, is quite simply unfounded.” The
    political (i.e., public policy) process never ceases and LPA’s next
    focus will undoubtedly be ensuring that their RxP services are
    expressly reimbursed and that there is no treatment locus (e.g.,
    inpatient care) in which artificial barriers are imposed upon their
    clinical expertise. In this regards, I want to personally express my
    appreciation for our HPA President’s vision in establishing our first
    HPA political action committee (PAC). Tanya’s efforts will
    undoubtedly make a significant difference for generations to come.
  2. edieb

    edieb Senior Member
    10+ Year Member

    Aug 27, 2004
    Likes Received:
    QUICK SEARCH: [advanced]

    Year: Vol: Page:

    Institution: LOUISIANA STATE UNIVERSIT Sign In as Member/Non-member

    This Article

    Full Text (PDF)
    Alert me when this article is cited
    Alert me if a correction is posted


    Email this article to a Colleague
    Similar articles in this journal
    Similar articles in PubMed
    Alert me to new issues of the journal
    Add to My Articles & Searches
    Download to citation manager

    Google Scholar

    Articles by Ensign, J. S.
    Articles citing this Article


    PubMed Citation
    Articles by Ensign, J. S.

    Related Collections

    Minority Issues

    Crisis and Emergency Treatment

    Health Policy and Legislation

    Quality of Care, Practice Guidelines

    Education, Nonmedical Psychiatric Professionals


    Atypical Neuroleptics

    Conventional Neuroleptics

    Psychiatr Serv 56:219, February 2005
    © 2005 American Psychiatric Association

    A Patient's Perspective on Psychologist Prescribing
    To the Editor: Contributors to the Patient Safety Forum in the December issue debated the contentious question of psychologist prescribing (1). In the hope that your readersare interested not only in the views of the two "warring factions" but also inthose of patients, I am writing to offer my observations as a consumer of psychiatric services for more than 30 years.
    A majority of prescriptions for antidepressants and anxiolytics are currently written by internists and general practitioners. These physicians are poorly trained to make initial psychiatric diagnoses and have little time for follow-up assessments. Few can remain current with the deluge of new research information pertaining to the myriad conditions theyencounter on adaily basis, such as congestive heart failure, diabetes, dyslipidemia, and autoimmune diseases. Swamped by new information,internists and general practitioners are understandably susceptible to marketing messages from sales representatives hawking the latest minor modification to an antidepressant that is being touted as "an important clinical breakthrough."

    Fortunately, serious errors in prescribing are nearly impossible in view of the fact that the similarities between the leading drugs to treat depression and anxiety disorders vastly exceed their relatively trivial differences. Indeed, the most serious treatment errors made by internists and general practitioners in this area areapt to be overlooking the value of psychotherapy or selecting a new branded drug when a generic would do. The homogeneity among these classes of drugs also enormously simplifies prescribing for psychologists. Furthermore, because psychologists are unlikely to be high-volume prescribers, they would attract fewer visits from sales representatives offering "information" and drug samples that may improperly influence treatment selection.

    Dr. Scully makes the point that "many nonpsychiatric illnesses cause or worsen psychiatric symptoms ... [including] endocrine disorders, diabetes, malignancies, heart disease, and infections." The implication is that psychologists would likely overlook these problems. I have been treated by six psychiatrists during my years of experiencing depression and anxiety, and none has yet suggested that drug therapy be preceded by a battery of tests to detect any occult illness. These psychiatrists were all board certified; two were from the National Institute of Mental Health, and one was the former medical director of a large psychiatric hospital. Clearly, precious little in the way of medical triaging is being offered in psychiatrists' offices—most likely because it simply is not necessary.

    Until there are meaningful clinical differences between drugs used to treat the most common psychiatric disorders, or an accurate way to predict patients' responses to the drugs, psychologists who are well trained in basic psychopharmacology are likely to offer pharmacologic care of equal or higher quality than that offered by general practitioners and internists. Indeed, psychologists' awareness of the added scrutiny that their treatment selections may attract is apt to foster a far more circumspect approach to prescribing—and a willingness to make referrals to specialists—than prevails in the current system.

    It is time that professionals set aside their claims about who "cares more" about patients' welfare and instead allow progress in clinical care to supersede petty turf battles.

    John S. Ensign, M.P.H.


    Mr. Ensign, who lives in Shirley, Massachusetts, was formerly a public health advisor at the U.S. Food and Drug Administration. He is currently employed as an independent pharmaceutical market analyst.


    Should psychologists have prescribing authority? Psychiatric Services 55:1420–1426,
  3. PublicHealth

    PublicHealth Membership Revoked

    Mar 18, 2003
    Likes Received:

    This sounds like Pat DeLeon -- "Mahalo" gave it away.
  4. PsyDRxPnow

    PsyDRxPnow Clinical Psychology
    5+ Year Member

    Oct 29, 2004
    Likes Received:
    Good for you and your patients :)
    Stop hovering to collapse... Click to collapse... Hover to expand... Click to expand...

Share This Page